CRA Insights

Insider Trading & Market Manipulation Literature Watch: Q3 2022

October 21, 2022

In the Insider Trading & Market Manipulation Literature Watch, members of our Finance Practice provide summaries and links to published research about insider trading and market manipulation. The team will provide an update each quarter.

The authors’ own abstracts are included in the newsletter and are unedited. Links to the full paper are provided. The inclusion of a paper in this newsletter does not signify that CRA or any of its experts agree or disagree with the content or conclusions therein.

In this edition, we feature pieces including a paper analyzing routine sales by insiders that occur between 2015 and 2020; an article on insider trading in the clinical trial setting; a paper examining whether the audit process facilitates informed trading by corporate insiders; a study evaluating geographic connections to China and insider trading at the start of the COVID-19 pandemic; an article considering whether securities market strategies designed to profit at the expense of so called “internalizers” should properly be considered illegal manipulation; a paper investigating differential responses by managers to institutional investors during site visits and to retail investors during online Q&As; and a study suggesting improvements in the existing EU anti-manipulation law and enforcement regime with a number of policy proposals.

Additional contributors